home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A Key Initiator Of Allergy And Asthma

 
  September, 7 2005 4:33
your information resource in human molecular genetics
 
     
Mice that express a particular protein in their lungs develop an asthma-like disease very similar to human asthma and other allergic inflammatory diseases. This new finding reported in the September issue of Nature Immunology opens up new ways of studying how disabling lung inflammation may be prevented.

Asthma is the most common serious chronic disease of childhood, affecting nearly five million children in the United States alone. The hallmarks of human asthma and allergy include increased numbers of immune cells in lung tissue. These cells are the key players responsible for secreting inflammatory factors that lead to the clinical symptoms associated with asthma. Many of the processes that subsequently lead to severe lung inflammation are known and most current treatments for allergy and asthma are aimed at blocking them. Unfortunately, most of these treatments only alleviate symptoms rather than prevent their underlying causes.

Steven Ziegler and colleagues provide clues that may allow treatments to prevent lung inflammation from occurring in the first place. The team studied a protein already known to be associated with inflammation, thymic stromal lymphopoetin (TSLP), to see if it was also responsible for symptoms of severe lung inflammation in mice. Mice that produced TSLP specifically in lung cells showed greatly increased disease that had most of the hallmarks of human asthma and other allergic inflammatory diseases. Zeigler and colleagues also evaluated mice that were deficient in TSLP, and these mice showed few signs of lung inflammation and failed to develop asthma-like disease.

Importantly, this work shows that a single protein is a key factor in the appearance of lung inflammatory disease, which may open up new avenues of research into treatments that prevent lung inflammation before the onset of debilitating symptoms.

Author contact:

Steven Ziegler (Benaroya Research Institute, Seattle, WA, USA)
E-mail: sziegler@benaroyaresearch.org

For abstract, click here.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.